Despite this, the difference in MYD88 expression observed in this analysis, which was approximately fourfold greater in malignant RS cells than in CLL cells, may indicate other mechanisms of transcriptional regulation of this molecule. The gene discussed is MYD88; the disease is B-cell chronic lymphocytic leukemia.